Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

0.52 

-0.01 -1.9%

as of Sep 28 '22

52 Week Range:

0.50 0.66


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group segment engages in the provision of medical services; hospital and healthcare management; and import and export trading businesses, as well as trading of medical-related goods. The company is also involved in the provision of medical technology; hospital digitalization, construction, and management services; property management; and medical consulting services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 0.22
0.48
0.52
0.58
0.78
0.84
1.06
growth rate 118.2% 8.3% 11.5% 34.5% 7.7% 26.2%
Avg.PE 11.85
11.22
6.53
6.72
4.44
4.92
4.06
growth rate -5.3% -41.8% 2.9% -33.9% 10.8% -17.5%
ROA 2.79
3.29
3.32
3.44
3.18
2.83
2.76
2.79
growth rate 17.9% 0.9% 3.6% -7.6% -11.0% -2.5% 1.1%
ROE 18.81
15.85
14.01
16.36
15.44
14.05
13.98
13.50
growth rate -15.7% -11.6% 16.8% -5.6% -9.0% -0.5% -3.4%
ROIC 3.02
3.42
3.40
3.49
3.23
2.95
3.07
3.09
growth rate 13.3% -0.6% 2.7% -7.5% -8.7% 4.1% 0.7%
Cur. Ratio 0.88
0.98
1.25
0.98
1.06
1.10
0.94
1.33
growth rate 11.4% 27.6% -21.6% 8.2% 3.8% -14.6% 41.5%
Quick Ratio 0.86
0.96
1.16
0.90
1.02
1.06
0.90
1.26
growth rate 11.6% 20.8% -22.4% 13.3% 3.9% -15.1% 40.0%
Leverage 6.75
4.02
4.41
5.05
4.70
5.19
4.95
4.73
growth rate -40.4% 9.7% 14.5% -6.9% 10.4% -4.6% -4.4%
Balance Sheet Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 9,580.22
15,673.88
21,346.26
26,774.41
34,592.89
43,724.72
49,830.64
54,395.73
60,814.18
growth rate 63.6% 36.2% 25.4% 29.2% 26.4% 14.0% 9.2% 11.8%
Acct.Payable 234.60
956.42
94.77
194.33
264.70
482.38
1,289.44
868.40
1,111.98
growth rate 307.7% -90.1% 105.1% 36.2% 82.2% 167.3% -32.7% 28.1%
Cur.Assets 10,150.91
16,231.25
23,360.62
28,730.83
37,312.79
46,504.88
54,122.92
57,365.26
64,511.26
growth rate 59.9% 43.9% 23.0% 29.9% 24.6% 16.4% 6.0% 12.5%
Total Assets 10,452.43
16,385.32
23,657.88
28,964.58
37,732.51
47,256.93
57,852.54
61,511.01
69,899.80
growth rate 56.8% 44.4% 22.4% 30.3% 25.2% 22.4% 6.3% 13.6%
Cash 319.00
453.57
1,865.67
1,272.46
1,749.88
2,173.47
3,385.87
2,036.54
2,342.08
growth rate 42.2% 311.3% -31.8% 37.5% 24.2% 55.8% -39.9% 15.0%
Inventory 3.32
3.12
2.64
2.05
21.05
40.54
156.73
198.03
265.43
growth rate -6.1% -15.3% -22.3% 924.6% 92.6% 286.6% 26.4% 34.0%
Cur.Liabilities 3,992.25
5,412.45
8,151.30
7,174.72
12,160.76
13,826.32
18,757.91
23,319.67
18,731.30
growth rate 35.6% 50.6% -12.0% 69.5% 13.7% 35.7% 24.3% -19.7%
Liabilities 9,283.69
13,957.82
17,776.68
22,390.19
30,263.69
37,000.12
44,405.33
46,545.68
52,276.55
growth rate 50.4% 27.4% 26.0% 35.2% 22.3% 20.0% 4.8% 12.3%
LT Debt 4,553.27
6,786.35
7,619.14
13,200.56
14,523.66
19,669.33
21,142.17
18,733.42
28,854.65
growth rate 49.0% 12.3% 73.3% 10.0% 35.4% 7.5% -11.4% 54.0%
Equity 1,168.74
2,427.50
5,881.20
6,574.39
7,468.60
10,048.09
11,141.69
12,422.90
14,765.83
growth rate 107.7% 142.3% 11.8% 13.6% 34.5% 10.9% 11.5% 18.9%
Common Shares 775.29
1,270.00
1,484.00
1,716.00
1,716.00
4,327.84
4,327.84
4,327.84
5,297.25
growth rate 63.8% 16.9% 15.6% 0.0% 152.2% 0.0% 0.0% 22.4%
Cash Flow Statement Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 0.58
0.74
28.90
20.20
18.89
17.64
208.24
401.39
385.07
growth rate 27.3% 3,800.5% -30.1% -6.5% -6.6% 1,080.5% 92.8% -4.1%
Cash Dividends 77.94
77.94
8.26
188.48
254.45
336.79
407.21
454.12
482.98
growth rate 0.0% -89.4% 2,180.8% 35.0% 32.4% 20.9% 11.5% 6.4%
Cash From OA -4,119.42
-4,110.72
-4,452.39
-2,381.65
-5,072.15
-5,728.65
-1,823.91
-971.72
-1,400.57
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF per Share -0.55
-0.32
-0.28
-0.50
-0.52
0.22
-0.44
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% -100.0%
Sale Purchase of Stock 804.61
804.61
2,882.73
growth rate 0.0% 258.3%
FCF -4,120.00
-4,111.00
-5,350.00
-2,402.00
-5,091.00
-5,746.00
-2,032.00
-1,373.00
-1,786.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Income Statement Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 984.02
1,556.76
2,195.20
2,708.72
3,423.98
4,295.01
6,746.81
8,243.23
9,566.91
growth rate 58.2% 41.0% 23.4% 26.4% 25.4% 57.1% 22.2% 16.1%
Op.Income 374.13
620.26
849.93
1,188.26
1,655.52
1,957.97
2,264.31
2,281.71
2,650.31
growth rate 65.8% 37.0% 39.8% 39.3% 18.3% 15.7% 0.8% 16.2%
IBT 418.34
611.08
900.27
1,205.95
1,576.46
1,859.04
2,211.86
2,365.01
2,691.81
growth rate 46.1% 47.3% 34.0% 30.7% 17.9% 19.0% 6.9% 13.8%
Net Income 312.74
456.64
658.53
872.31
1,148.66
1,352.17
1,588.34
1,747.14
1,947.73
growth rate 46.0% 44.2% 32.5% 31.7% 17.7% 17.5% 10.0% 11.5%
EPS 0.36
0.44
0.51
0.67
0.79
0.87
0.96
0.91
growth rate 22.2% 15.9% 31.4% 17.9% 10.1% 10.3% -5.2%
Gross Profit 635.40
937.17
1,310.35
1,742.75
2,179.34
2,589.57
3,110.31
3,275.97
3,852.07
growth rate 47.5% 39.8% 33.0% 25.1% 18.8% 20.1% 5.3% 17.6%

Quarterly Statements

Item Name Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Balance Sheet
Acct.Receivable 54,395.73
60,721.93
60,721.93
60,814.18
60,814.18
growth rate 11.6% 0.0% 0.2% 0.0%
Acct.Payable 868.40
1,176.13
1,176.13
1,111.98
1,111.98
growth rate 35.4% 0.0% -5.5% 0.0%
Cur.Assets 57,365.26
65,474.63
65,474.63
64,511.26
64,511.26
growth rate 14.1% 0.0% -1.5% 0.0%
Total Assets 61,511.01
69,894.95
69,894.95
69,899.80
69,899.80
growth rate 13.6% 0.0% 0.0% 0.0%
Cash 2,036.54
3,212.18
3,212.18
2,342.08
2,342.08
growth rate 57.7% 0.0% -27.1% 0.0%
Inventory 198.03
236.73
236.73
265.43
265.43
growth rate 19.5% 0.0% 12.1% 0.0%
Cur.Liabilities 23,319.67
23,835.45
23,835.45
18,731.30
18,731.30
growth rate 2.2% 0.0% -21.4% 0.0%
Liabilities 46,545.68
52,549.73
52,549.73
52,276.55
52,276.55
growth rate 12.9% 0.0% -0.5% 0.0%
LT Debt 18,733.42
24,389.52
24,389.52
28,854.65
28,854.65
growth rate 30.2% 0.0% 18.3% 0.0%
Equity 12,422.90
14,549.01
14,549.01
14,765.83
14,765.83
growth rate 17.1% 0.0% 1.5% 0.0%
Common Shares 4,327.84
5,297.25
5,297.25
5,297.25
5,297.25
growth rate 22.4% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Capital Expenditures 107.29
62.84
62.84
129.69
129.69
growth rate -41.4% 0.0% 106.4% 0.0%
Cash Dividends 241.49
241.49
241.49
growth rate 0.0% 0.0%
Cash From OA -792.85
-2,026.91
-2,026.91
1,326.62
1,326.62
growth rate 0.0% 0.0% 100.0% 0.0%
FCF -900.14
-2,089.75
-2,089.75
1,196.93
1,196.93
growth rate 0.0% 0.0% 100.0% 0.0%
Income Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Sales 2,231.37
2,411.38
2,411.38
2,372.07
2,372.07
growth rate 8.1% 0.0% -1.6% 0.0%
Op.Income 624.29
769.08
769.08
556.08
556.08
growth rate 23.2% 0.0% -27.7% 0.0%
IBT 618.41
737.76
737.76
608.15
608.15
growth rate 19.3% 0.0% -17.6% 0.0%
Net Income 451.97
542.78
542.78
431.09
431.09
growth rate 20.1% 0.0% -20.6% 0.0%
Gross Profit 902.92
1,089.43
1,089.43
836.61
836.61
growth rate 20.7% 0.0% -23.2% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (48.88)

YOY Growth Grade:

C (52.89)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 4.31 4.23
EPS / Growth 0.12

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 20.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 20.9% 20.9% 20.9%
Future PE 0.01 2.88 15.37
Future EPS 0.82 0.82 0.82
Value Price
MOS %
0.00
-99.6%
0.58
12.1%
3.11
499.0%
MOS Price 0.00 0.29 1.56
IRT 2.88 2.88 2.88

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.